Single-cell biology has transformed how we decode cellular heterogeneity, but a new frontier is emerging: understanding what ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already ...

Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations ...

Although gene-editing and other techniques can improve the production of microbe-based biologics, AI could push these drugs ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

The ECOnti project's aim is to fit the entire manufacturing site into a small footprint as part of bioproduction democratization.

The signature seems consistent across CRPS populations irrespective of diet, geography, and other factors, and it persists ...

Attributing manufacturing problems to “human error” is an oversimplification that can mask deeper failures, according to Ann Ryan, head of business development at Ireland-based training and technology ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the condition.

Astraveus' technology possesses the ability to simultaneously decrease manufacturing costs while increasing process efficiency and throughput.

Base-editing technologies along with AAV engineering not only help reduce costs but can also accelerate preclinical therapeutic development.